The rest is here:
FDA approves Infant Bacterial Therapeutics' request for a new orphan drug designation

Read more from the original source:
InvestmentPitch Media Video Discusses Voyageur Pharmaceuticals’ Notice of Work with the BC Ministry of Mines, for the Removal of 2,000 Tonnes of...

See the original post:
ProKidney to Present at the Jefferies Cell and Genetic Medicine Summit

View post:
Arch Therapeutics Announces First Shipments of AC5® Advanced Wound System Under New Reimbursement Support Program

Go here to read the rest:
AEON Biopharma Reports Positive Topline Results from Phase 2 Clinical Trial of ABP-450 (prabotulinumtoxinA) in Cervical Dystonia

More here:
Tilray Brands, Inc. to Announce First Quarter Fiscal 2023 Financial Results on October 7, 2022

Excerpt from:
Belite Bio Announces Late-Breaking Presentation at the American Academy of Ophthalmology 2022 Annual Meeting

Continued here:
Humacyte Announces Presentations by Ukrainian Surgeons on Use of the Human Acellular Vessel™ to Treat Wartime Vascular Trauma at the European...

Continue reading here:
Adverum Biotechnologies Announces Upcoming Data Presentation at AAO 2022

Follow this link:
Immutep Receives A$2.7 million R&D Tax Incentive from French Government

Original post:
Jasper Therapeutics to Present at Upcoming Conferences

See original here:
Nautilus Biotechnology to Participate in the Capital One Spatial Biology & Proteomics Summit

Read the original:
Alimera Announces Agreement with Jaeb Center for Health Research on Behalf of the DRCR Retina Network

View original post here:
Rhythm Pharmaceuticals Announces Publication of Children’s Book for Patients and Families Living with Bardet-Biedl Syndrome (BBS)

Read more:
Allogene Therapeutics Announces Participation in the Jefferies Cell and Genetic Medicine Summit

Read the original here:
Oncternal Therapeutics to Participate in the Cantor Oncology, Hematology & HemeOnc Conference

View post:
ABVC BioPharma Provides ADHD Phase II Part 2 Clinical Study Update and Announces UCSF Institutional Review Board Approval

Read more from the original source:
InMed Pharmaceuticals Reports Full Year Fiscal 2022 Financial Results and Provides Business Update

Continued here:
Adverum Biotechnologies to Participate in the Jefferies Cell and Genetic Medicine Summit

See the original post:
Palisade Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)